HIGHLIGHTS
- who: . and colleagues from the University of Bologna, Italy have published the article: Systems biology reveals anatabine to be an NRF2 activator, in the Journal: (JOURNAL)
- what: During this period, an open-label case series showed that a facial cream containing anatabine could improve the appearance of skin in patients with mild to moderate rosacea (Lanier et_al, 2013a), while an internet-based survey study provided evidence that anatabine supplementation could improve chronic joint pain disorders (Lanier et_al, 2013b). Since these proteins are target genes of the NRF2 transcription factor, and the gene_expression enrichment results also . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.